Nok Therapeutics, Inc.

CIK 2038166 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nok Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 15, 20261-U0001213900-26-078262
Jun 3, 20261-U0001213900-26-064632
May 1, 2026D/A0001213900-26-050987
May 1, 2026D/A0001213900-26-050994
Apr 30, 20261-K0001213900-26-050128
Apr 22, 2026D/A0001213900-26-046528
Apr 22, 2026D/A0001213900-26-046533
Apr 22, 2026D/A0001213900-26-046538
Mar 26, 2026D0001213900-26-034315
Oct 24, 2025D0001213900-25-102039
Oct 24, 2025D0001213900-25-102036
Sep 30, 20251-SA0001213900-25-093298
May 6, 20251-K0001213900-25-040030
Jan 3, 2025QUALIF9999999994-25-000002
Dec 23, 20241-A/A0001213900-24-111515
Dec 17, 20241-A/A0001213900-24-109593
Dec 9, 20241-A/A0001213900-24-106784
Nov 26, 20241-A/A0001213900-24-102942
Nov 25, 20241-A/A0001213900-24-102085
Nov 7, 20241-A/A0001213900-24-095370
Sep 26, 20241-A0001213900-24-082240